Rachèl Kemps
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rachèl Kemps has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Marita Partanen
Princess Máxima Center for Pediatric Oncology Utrecht the Netherlands
2 shared publications- Marita Partanen
Princess Máxima Center for Pediatric Oncology , Utrecht
2 shared publications - Alberto De Luca
UMC Utrecht
1 shared publication - Alison Margaret Colbert
University of Colorado School of Medicine
1 shared publication - Anne E M Leenders
Princess Máxima Center for Pediatric Oncology , Utrecht
1 shared publication - Bruno M. de Brito Robalo
Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Center , Rotterdam
1 shared publication
Latest Publications
- Open Access
- 10 January 2026
- Published by Springer Nature in Trials
- Vol. 27 (1)
ERNIE—Evaluating Response to an individualized Neuropsychological IntervEntion for children with brain tumors: study protocol for a randomized controlled trial
Although survival rates for children with brain tumors have improved, many face neuropsychological challenges that can affect quality of life and daily fun
- 10 January 2026
- Published by Springer Nature in Trials
- Vol. 27 (1)
Open AccessERNIE—Evaluating Response to an individualized Neuropsychological IntervEntion for children with brain tumors: study protocol for a randomized controlled trial
Although survival rates for children with brain tumors have improved, many face neuropsychological challenges that can affect quality of life and daily fun
- Open Access
- 1 August 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (10) , e31955
Posttraumatic Stress Symptoms in Children and Parents Shortly After Pediatric Brain Tumor Diagnosis: Prevalence and Risk Factors
Background: Posttraumatic stress symptoms (PTSS) are high amongst survivors of pediatric brain tumors and their parents; however, early prevalence is unknown. This study aimed to get insight into the prevalence and risk factors of child and parental PTSS shortly after diagnosis.Procedures: Sixty‐five children with brain tumors (6–16 years old) and their parents participated. The prevalence of clinical child PTSS (CRIES‐13 self‐ and proxy‐report) and parental PTSS (PCL‐5) was assessed 1–3 months after diagnosis, and compared to the general population (PCL‐5; binomial test). Pearson's correlations between child and parental PTSS were calculated. Risk factors were explored with linear regression analyses (psychosocial risk assessed through PAT).Results: Clinical child PTSS scores were reported by 29.4% of the children (self‐report) and 11.1% of their parents (proxy‐report). Prevalence of clinical parental PTSS was not significantly higher than in the general population (mothers: 12.1%, p = 0.07; fathers: 6.0%, p = 0.20). Self‐reported child PTSS scores were associated with proxy‐reported child PTSS scores (r = 0.49, p < 0.001), but not with parental PTSS scores (mother r = 0.22, father r = 0.18). No associations were found between demographic factors and child or parental PTSS. Shorter time since diagnosis was associated with more self‐reported child PTSS (β = −0.45, p = 0.01). Starting radiotherapy was associated with more mother PTSS (β = 1.04, p < 0.003). Family psychosocial risk was associated with more child PTSS (self‐report β = 0.82, p = 0.02; proxy‐report β = 0.81, p = 0.02) and mother PTSS (β = 1.33, p < 0.001).Conclusions: Prevalence of PTSS in children with recently diagnosed brain tumors was high, highlighting the need for early psychosocial monitoring and targeted interventions to optimize health‐related quality of life.
- 1 August 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (10) , e31955
Open AccessPosttraumatic Stress Symptoms in Children and Parents Shortly After Pediatric Brain Tumor Diagnosis: Prevalence and Risk Factors
Background: Posttraumatic stress symptoms (PTSS) are high amongst survivors of pediatric brain tumors and their parents; however, early prevalence is unknown. This study aimed to get insight into the prevalence and risk factors of child and parental PTSS shortly after diagnosis.Procedures: Sixty‐five children with brain tumors (6–16 years old) and their parents participated. The prevalence of clinical child PTSS (CRIES‐13 self‐ and proxy‐report) and parental PTSS (PCL‐5) was assessed 1–3 months after diagnosis, and compared to the general population (PCL‐5; binomial test). Pearson's correlations between child and parental PTSS were calculated. Risk factors were explored with linear regression analyses (psychosocial risk assessed through PAT).Results: Clinical child PTSS scores were reported by 29.4% of the children (self‐report) and 11.1% of their parents (proxy‐report). Prevalence of clinical parental PTSS was not significantly higher than in the general population (mothers: 12.1%, p = 0.07; fathers: 6.0%, p = 0.20). Self‐reported child PTSS scores were associated with proxy‐reported child PTSS scores (r = 0.49, p < 0.001), but not with parental PTSS scores (mother r = 0.22, father r = 0.18). No associations were found between demographic factors and child or parental PTSS. Shorter time since diagnosis was associated with more self‐reported child PTSS (β = −0.45, p = 0.01). Starting radiotherapy was associated with more mother PTSS (β = 1.04, p < 0.003). Family psychosocial risk was associated with more child PTSS (self‐report β = 0.82, p = 0.02; proxy‐report β = 0.81, p = 0.02) and mother PTSS (β = 1.33, p < 0.001).Conclusions: Prevalence of PTSS in children with recently diagnosed brain tumors was high, highlighting the need for early psychosocial monitoring and targeted interventions to optimize health‐related quality of life.
- 1 April 2024
- Published by Hogrefe Publishing Group in International Perspectives in Psychology: Research, Practice, Consultation
- Vol. 13 (2) , 79-87
Cross-Cultural Collaborative Translation/Adaptation of Assessments Via International Working Groups
Most neuropsychological assessments are developed in English, yet nearly 95% of the global population are not native English speakers. To further compound this problem, translating and adapting assessments is a complex, expensive, and time-consuming process that few individual psychologists can undertake on their own. To overcome these obstacles, we formed an international consulting group of bilingual pediatric rehabilitation/hospital clinicians to translate and adapt a common assessment of cognitive recovery, the Cognitive and Linguistic Scale (CALS), for use with youth in three linguistic/cultural groups: Spanish-speaking youth residing in the United States, Dutch-speaking youth residing in the Netherlands, and Hebrew-speaking youth residing in Israel. We describe the collaborative process of translating and adapting the CALS for the respective populations following the first two stages of the International Test Committee guidelines (Precondition and Test Development). We also present new, more culturally accessible versions of visual stimuli that can be used across many linguistic/cultural groups in the Western world. Initial examination of responses from a preliminary pilot sample of US youth ( N = 11) supported the acceptability of the Spanish translation and new visual stimuli. Next steps for each translated/adapted version of the CALS are discussed, including plans for validation in each respective population. We hope this overview will serve as a model for other groups to help decrease the translation burden on individual clinicians and promote higher-quality translated/adapted assessments that better serve diverse and often underserved patient populations.
- 1 April 2024
- Published by Hogrefe Publishing Group in International Perspectives in Psychology: Research, Practice, Consultation
- Vol. 13 (2) , 79-87
Cross-Cultural Collaborative Translation/Adaptation of Assessments Via International Working Groups
Most neuropsychological assessments are developed in English, yet nearly 95% of the global population are not native English speakers. To further compound this problem, translating and adapting assessments is a complex, expensive, and time-consuming process that few individual psychologists can undertake on their own. To overcome these obstacles, we formed an international consulting group of bilingual pediatric rehabilitation/hospital clinicians to translate and adapt a common assessment of cognitive recovery, the Cognitive and Linguistic Scale (CALS), for use with youth in three linguistic/cultural groups: Spanish-speaking youth residing in the United States, Dutch-speaking youth residing in the Netherlands, and Hebrew-speaking youth residing in Israel. We describe the collaborative process of translating and adapting the CALS for the respective populations following the first two stages of the International Test Committee guidelines (Precondition and Test Development). We also present new, more culturally accessible versions of visual stimuli that can be used across many linguistic/cultural groups in the Western world. Initial examination of responses from a preliminary pilot sample of US youth ( N = 11) supported the acceptability of the Spanish translation and new visual stimuli. Next steps for each translated/adapted version of the CALS are discussed, including plans for validation in each respective population. We hope this overview will serve as a model for other groups to help decrease the translation burden on individual clinicians and promote higher-quality translated/adapted assessments that better serve diverse and often underserved patient populations.
- Open Access
- 1 January 2024
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 6 (1) , vdae026
Unraveling the relations between post-traumatic stress symptoms, neurocognitive functioning, and limbic white matter in pediatric brain tumor patients
Pediatric brain tumor patients are at risk of developing neurocognitive impairments and associated white matter alterations. In other populations, post-traumatic stress symptoms (PTSS) impact cognition and white matter. This study aims to investigate the effect of PTSS on neurocognitive functioning and limbic white matter in pediatric brain tumor patients. Sixty-six patients (6–16 years) completed neuropsychological assessment and brain MRI (1-year post-diagnosis) and parents completed PTSS proxy questionnaires (CRIES-13; 1–3 months and 1-year post-diagnosis). Mean Z-scores and percentage impaired (>1SD) for attention, processing speed, executive functioning, and memory were compared to normscores (t-tests, chi-square tests). Multi-shell diffusion MRI data were analyzed for white matter tractography (fractional anisotropy/axial diffusivity). Effects of PTSS on neurocognition and white matter were explored with linear regression models (FDR correction for multiple testing), including age at diagnosis, treatment intensity, and tumor location as covariates. Neurocognition and limbic white matter associations were explored with correlations. Attention (M = −0.49, 33% impaired; P < .05) and processing speed (M = −0.57, 34% impaired; P < .05) were significantly lower than healthy peers. PTSS was associated with poorer processing speed (β = −0.64, P < .01). Treatment intensity, age at diagnosis, and tumor location, but not PTSS, were associated with limbic white matter metrics. Neurocognition and white matter metrics were not associated. Higher PTSS was associated with poorer processing speed, highlighting the need for monitoring, and timely referrals to optimize psychological well-being and neurocognitive functioning. Future research should focus on longitudinal follow-up and explore the impact of PTSS interventions on neurocognitive performance.
- 1 January 2024
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 6 (1) , vdae026
Open AccessUnraveling the relations between post-traumatic stress symptoms, neurocognitive functioning, and limbic white matter in pediatric brain tumor patients
Pediatric brain tumor patients are at risk of developing neurocognitive impairments and associated white matter alterations. In other populations, post-traumatic stress symptoms (PTSS) impact cognition and white matter. This study aims to investigate the effect of PTSS on neurocognitive functioning and limbic white matter in pediatric brain tumor patients. Sixty-six patients (6–16 years) completed neuropsychological assessment and brain MRI (1-year post-diagnosis) and parents completed PTSS proxy questionnaires (CRIES-13; 1–3 months and 1-year post-diagnosis). Mean Z-scores and percentage impaired (>1SD) for attention, processing speed, executive functioning, and memory were compared to normscores (t-tests, chi-square tests). Multi-shell diffusion MRI data were analyzed for white matter tractography (fractional anisotropy/axial diffusivity). Effects of PTSS on neurocognition and white matter were explored with linear regression models (FDR correction for multiple testing), including age at diagnosis, treatment intensity, and tumor location as covariates. Neurocognition and limbic white matter associations were explored with correlations. Attention (M = −0.49, 33% impaired; P < .05) and processing speed (M = −0.57, 34% impaired; P < .05) were significantly lower than healthy peers. PTSS was associated with poorer processing speed (β = −0.64, P < .01). Treatment intensity, age at diagnosis, and tumor location, but not PTSS, were associated with limbic white matter metrics. Neurocognition and white matter metrics were not associated. Higher PTSS was associated with poorer processing speed, highlighting the need for monitoring, and timely referrals to optimize psychological well-being and neurocognitive functioning. Future research should focus on longitudinal follow-up and explore the impact of PTSS interventions on neurocognitive performance.